Title 201 | Chapter 002 | Regulation 416REG


PROPOSED
This document is not yet current.
View Current Regulation
PREVIOUS VERSION
The previous document that this document is based upon is available.
View Previous Version
BOARDS AND COMMISSIONS
Board of Pharmacy
(Amended at ARRS Committee)

201 KAR 2:416.Pharmacy annual reporting of cost of dispensing data.

Section 1.

Mandatory Submission of Data.

(1)

On an annual basis, no later thanbeginning March 1, 2026, and by March 1 every other year thereafter, every ambulatory pharmacy permitted by the Board of Pharmacy shall submit to the board, the following data, which shall remain confidential as required by and in accordance with KRS 315.038(6) and (7), relating to the dispensing costs for the previous year year which shall remain confidential and only be shared with the Department of Insurance as required by KRS 315.038:

(a)

NCPDP number;

(b)

Labor costs, including:

1.

Pharmacist salaries, including benefits and taxes;

2.

Pharmacy technician salaries, including benefits and taxes;

3.

Salaries of other support staff involved in the dispensing of prescriptions; and

4.

Other employee benefits;.

(c)

Cost to acquire the medications dispensed;

(d)

Cost of materials, including:

1.

Cost of prescription labels and paper;

2.

Cost of bottles, vials, and packaging;

3.

Prescription delivery costs;

4.

Inventory services costs;

5.

Lost inventory costs; and

6.

Warehouse expenses;.

(e)

Facility costs, including:

1.

Rent or mortgage payments for the pharmacy space. If the pharmacy shares a building with retail space, the proportion of the square footage that is permitted for pharmacy operations shall be applied to the total rent for the building;

2.

Mortgage interest;

3.

Utilities, including electricity, water, heating, and communications costs;

4.

Facility taxes, including personal property, real estate, and payroll, and as well as insurance;

5.

Maintenance, cleaning and repair costs; and

6.

Security and alarm fees;.

(f)

Operational costs, including:

1.

Insurance, including liability and property;

2.

Software and IT systems;

3.

Switch or e-prescribing fees;

4.

Office supplies and equipment;

5.

Professional liability insurance for pharmacists;

6.

Credit card processing fees;

7.

Prescription department licenses, permits, accreditation, and fees;

8.

Cost of continuing education and certification for pharmacists and technicians;

9.

Dues and subscriptions for pharmacy department;

10.

Delivery and mailing expenses for the prescription department;

11.

Transaction fees;

12.

Charitable contributions;

13.

Employee training;

14.

Bad debts for prescriptions, including uncollected copays; and

15.

Third-partyThird party prescriptions audit adjustments;.

(g)

Store costs, including:

1.

Marketing and advertising;

2.

Professional accounting and legal services;

3.

Franchise fees, if applicable; and

4.

Other costs not otherwise listed in this subsection;included elsewhere.

(h)

Depreciation and amortization costs, including:

1.

Depreciation of building, equipment, and fixtures; and

2.

Amortization of software and intangible assets;.

(i)

Total number of prescriptions dispensed each month of the prior year; and

(j)

Total number of prescriptions prepared via a central fill pharmacy each month of the prior year; and

(k)

Percent of revenue coming directly from the pharmacy department.

(2)

All data shall be reported to the board electronically through the board's licensing gateway on Reporting Form A, Pharmacy Cost of Dispensing Data, 12/2024. Data may be submitted in the aggregate for pharmacies with multiple locations.

Section 2.

Optional Submission of Data.

(1)

On an annual basis, beginning March 1, 2026 and by March 1 every year thereafter, any ambulatory pharmacy permitted by the Board of Pharmacy may submit to the board, the following data for each prescription dispensed:

(a)

The date the claim was submitted to the pharmacy benefit manager;

(b)

The date the prescription was written;

(c)

The NCPDP transaction type;

(d)

The prescription insurance member identification number;

(e)

The prescription number assigned by the pharmacy;

(f)

The number of the refill;

(g)

The NDC number of the product dispensed;

(h)

The name of the product dispensed;

(i)

The strength of the medication dispensed;

(j)

The quantity of the medication dispensed;

(k)

The days'days supply of medication dispensed;

(l)

Whether or not the medication dispensed was generic;

(m)

Whether or not the medication dispensed was a specialty drug;

(n)

The NABP identification number of the pharmacy where the medication was dispensed;

(o)

The NPI identification number of the pharmacy where the medication was dispensed;

(p)

The name of the pharmacy where the medication was dispensed;

(q)

The amount, in dollars, paid to the pharmacy by the prescription benefit plan;

(r)

The amount, in dollars, paid to the pharmacy by the health plan member;

(s)

The total amount, in dollars, paid to the pharmacy for the prescription dispensed, including what the patient paid and what the health plan paid;

(t)

The amount, in dollars, paid to the pharmacy for dispensing the medication; and

(u)

The amount, (in dollars,) of retroactive fees that were assessed to the pharmacy by the pharmacy benefit manager for the medication dispensed at any time after the medication was dispensed, including, but not limited to:

1.

Direct remuneration fees;

2.

Indirect renumeration fees;

3.

Generic effective ratesrats;

4.

In-network fees;

5.

Performance fees;

6.

Point-of-sale fees; and

7.

Pre and post adjudication fees.

(2)

If the pharmacy chooses to submit this data, the data shall be reported to the board electronically through the board's licensing gateway on Reporting Form B, Pharmacy Claims Data, 12/2024.

Section 3.

All information and data submitted to the board shall be deemed confidential and proprietary and shall not be subject to disclosure pursuant to KRS 61.870 to 61.884. Only board staff will have access to the data submitted. Board of Pharmacy members shallwill not have access to the data submitted.

Section 4.

Enforcement discretion shallwill be exercised if a pharmacy that does not bill third parties fails to submit mandatory data under Section 1 of this administrative regulation if they do not bill third parties.

Section 5.

Incorporation by Reference.

(1)

The following material is incorporated by reference:

(a)

"Reporting Form A, Pharmacy Cost of Dispensing Data", Reporting Form A, 12/2024; and

(b)

"Reporting Form B, Pharmacy Claims Data", Reporting Form B, 12/2024.

(2)

This material may be inspected, copied, or obtained, subject to applicable copyright law at the Kentucky Board of Pharmacy, State Office Building Annex, Suite 300, 125 Holmes Street, Frankfort, Kentucky 40601, Monday through Friday, 8 a.m. to 4:30 p.m. or on the websiteWeb site at https://pharmacy.ky.gov/Businesses/Pages/Pharmacy.aspx.

FILED WITH LRC: July 14, 2025 at 3 p.m.
CONTACT PERSON: Christopher Harlow, Executive Director, Kentucky Board of Pharmacy, 125 Holmes Street, Suite 300, State Office Building Annex, Frankfort, Kentucky 40601, phone (502) 564-7910, fax (502) 696-3806, email Christopher.harlow@ky.gov.

7-Year Expiration: 12/18/2031

Last Updated: 7/21/2025


Page Generated: 2/4/2025, 3:28:47 PM